chr19-36183548-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_152477.5(ZNF565):c.418G>A(p.Val140Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000613 in 1,614,198 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_152477.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF565 | NM_152477.5 | c.418G>A | p.Val140Ile | missense_variant | 5/5 | ENST00000304116.10 | NP_689690.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF565 | ENST00000304116.10 | c.418G>A | p.Val140Ile | missense_variant | 5/5 | 2 | NM_152477.5 | ENSP00000306869.5 | ||
ZNF565 | ENST00000591473.1 | c.223G>A | p.Val75Ile | missense_variant | 4/4 | 1 | ENSP00000465906.1 | |||
ZNF565 | ENST00000355114.9 | c.538G>A | p.Val180Ile | missense_variant | 5/5 | 2 | ENSP00000347234.5 | |||
ZNF565 | ENST00000392173.6 | c.418G>A | p.Val140Ile | missense_variant | 5/5 | 2 | ENSP00000376013.1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152188Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251474Hom.: 1 AF XY: 0.0000883 AC XY: 12AN XY: 135906
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461892Hom.: 2 Cov.: 33 AF XY: 0.0000481 AC XY: 35AN XY: 727246
GnomAD4 genome AF: 0.000171 AC: 26AN: 152306Hom.: 0 Cov.: 30 AF XY: 0.000161 AC XY: 12AN XY: 74458
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 24, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at